← Back to Clinical Trials
Recruiting NCT04187729

NCT04187729 Precision Genomics Medicine Biobank

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04187729
Status Recruiting
Phase —
Sponsor Intermountain Health Care, Inc.
Condition Any Disease Condition and Reportedly-healthy Subjects
Study Type OBSERVATIONAL
Enrollment 100,000 participants
Start Date 2017-10-24
Primary Completion 2067-10-24

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100,000 participants in total. It began in 2017-10-24 with a primary completion date of 2067-10-24.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and prognostic potential.

Eligibility Criteria

Group #1 inclusion criteria * Male and female adults (≥ 18 years of age) * Diagnosed with any healthcare-related condition(s) * Subject presenting to an Intermountain Healthcare facility Group #2 inclusion criteria * Male and female adults (≥ 18 years of age) * Reportedly healthy (i.e., non-diseased) * Subject presenting to an Intermountain Healthcare facility Groups #1 and 2 exclusion criteria * Inability or refusal of the patient and/or the patient's legally-acceptable representative to provide informed consent for any reason * Other conditions that the Principal Investigators or Co-Investigators believe may increase the risk to the subject and/or compromise the scientific integrity of the registry

Contact & Investigator

Central Contact

Tyler Barker, PhD

✉ tyler.barker@imail.org

📞 801-507-3653

Frequently Asked Questions

Who can join the NCT04187729 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Any Disease Condition and Reportedly-healthy Subjects. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04187729 currently recruiting?

Yes, NCT04187729 is actively recruiting participants. Contact the research team at tyler.barker@imail.org for enrollment information.

Where is the NCT04187729 trial being conducted?

This trial is being conducted at Murray, United States.

Who is sponsoring the NCT04187729 clinical trial?

NCT04187729 is sponsored by Intermountain Health Care, Inc.. The trial plans to enroll 100,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology